Novo Nordisk A/S vs Under Armour Inc Class A — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Under Armour Inc Class A trades at $7.3 (market cap $3.07B). The key difference: Novo Nordisk A/S is far larger — about 71.8× Under Armour Inc Class A's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.
| NVO | UAA | |
|---|---|---|
Market Cap | $220.53B | $3.07B |
Sector | Health | Consumer Cyclical |
52-Week High | $71.70 | $8.14 |
52-Week Low | $35.29 | $4.17 |
Enterprise Value | $239.49B | $4.70B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →